Nishizawa et al. preliminarily showed that RIOX1 was selectively expressed in human CRC tissues compared to normal tissues and was associated with metastatic malignant behavior and prognosis, whereas in vitro RIOX1 knockdown inhibited CRC cell proliferation, migration, and anti-apoptotic activity [175]. This evidence concerns the gene RIOX1 and colorectal carcinoma.